儿童肿瘤学组 2023 年研究蓝图：放射肿瘤学。
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
机构信息
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Memorial Sloan Kettering Cancer Center, New York, New York, USA.
出版信息
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30593. doi: 10.1002/pbc.30593. Epub 2023 Jul 24.
Abstract
Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.
摘要
放射肿瘤学是多学科团队治疗癌症儿童的一个组成部分。我们委员会的主要目标是通过使用调强放疗 (IMRT) 和质子治疗等先进技术，为儿童提供更低剂量的辐射治疗 (RT)，从而在最大程度上治愈肿瘤的同时将毒性降至最低。我们为年轻医生提供指导，并积极参与教育全球放射肿瘤学界。我们在寻找新的放射增敏剂、放射保护剂和先进的 RT 技术方面处于领先地位，这些技术有可能帮助改善癌症儿童的治疗效果。
相似文献
1
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.儿童肿瘤学组 2023 年研究蓝图：放射肿瘤学。
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30593. doi: 10.1002/pbc.30593. Epub 2023 Jul 24.
2
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.三维适形放疗与调强放疗在放射治疗肿瘤学组 0126 前列腺癌试验高剂量臂中的初步毒性分析。
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):932-8. doi: 10.1016/j.ijrobp.2013.07.041. Epub 2013 Oct 8.
3
Children's Oncology Group's 2013 blueprint for research: radiation oncology.儿童肿瘤学组 2013 年研究蓝图：放射肿瘤学。
Pediatr Blood Cancer. 2013 Jun;60(6):1037-43. doi: 10.1002/pbc.24425. Epub 2012 Dec 19.
4
Comparative effectiveness research in radiation oncology: assessing technology.放射肿瘤学中的比较效果研究：评估技术。
Semin Radiat Oncol. 2014 Jan;24(1):25-34. doi: 10.1016/j.semradonc.2013.08.003.
5
Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.儿童髓母细胞瘤的调强放射治疗：降低耳毒性的早期报告
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):599-605. doi: 10.1016/s0360-3016(01)02641-4.
6
Recent advances in radiation oncology: intensity-modulated radiotherapy, a clinical perspective.放射肿瘤学的最新进展：调强放射治疗，临床视角
Int J Clin Oncol. 2014 Aug;19(4):564-9. doi: 10.1007/s10147-014-0718-y. Epub 2014 Jul 2.
7
Intensity-modulated radiotherapy: current status and issues of interest.调强放射治疗：现状与关注问题
Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):880-914. doi: 10.1016/s0360-3016(01)01749-7.
8
Preoperative Intensity Modulated Radiation Therapy Compared to Three-Dimensional Conformal Radiation Therapy for High-Grade Extremity Sarcomas in Children: Analysis of the Children's Oncology Group Study ARST0332.术前调强放疗对比三维适形放疗用于儿童肢体高级别肉瘤：儿童肿瘤学组研究 ARST0332 的分析。
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):38-44. doi: 10.1016/j.ijrobp.2018.09.005. Epub 2018 Sep 10.
9
Technological evolution of radiation treatment: Implications for clinical applications.放射治疗技术的演变：对临床应用的影响。
Semin Oncol. 2019 Jun;46(3):193-201. doi: 10.1053/j.seminoncol.2019.07.004. Epub 2019 Jul 30.
10
Novel techniques in the delivery of radiation in pediatric oncology.儿科肿瘤学中放射治疗的新技术。
Pediatr Clin North Am. 2002 Oct;49(5):1107-29. doi: 10.1016/s0031-3955(02)00037-8.
引用本文的文献
1
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.下一代儿童肿瘤学组横纹肌肉瘤临床试验路线图。
Cancer. 2024 Nov 15;130(22):3785-3796. doi: 10.1002/cncr.35457. Epub 2024 Jun 28.
本文引用的文献
1
Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.难治性和复发性青少年及年轻成人霍奇金淋巴瘤的放射治疗应用：来自儿童肿瘤学组的报告。
Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):400-403. doi: 10.1016/j.ijrobp.2023.04.022. Epub 2023 Apr 26.
2
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy.正电子发射断层扫描反应适应放疗在儿科霍奇金淋巴瘤试验中进行中心影像学评估的重要性。
Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1025-1030. doi: 10.1016/j.ijrobp.2023.02.020. Epub 2023 Mar 2.
3
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.随机 III 期临床试验：甘替单抗联合间歇性化疗治疗新诊断转移性尤文肉瘤患者：来自儿童肿瘤协作组的报告。
J Clin Oncol. 2023 Apr 10;41(11):2098-2107. doi: 10.1200/JCO.22.01815. Epub 2023 Jan 20.
4
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.贝林妥欧单抗联合化疗治疗儿科高危霍奇金淋巴瘤。
N Engl J Med. 2022 Nov 3;387(18):1649-1660. doi: 10.1056/NEJMoa2206660.
5
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial.质子 FLASH 放疗治疗症状性骨转移：FAST-01 非随机试验。
JAMA Oncol. 2023 Jan 1;9(1):62-69. doi: 10.1001/jamaoncol.2022.5843.
6
Radiation Oncology: Future Vision for Quality Assurance and Data Management in Clinical Trials and Translational Science.放射肿瘤学：临床试验与转化科学中质量保证和数据管理的未来愿景。
Front Oncol. 2022 Aug 10;12:931294. doi: 10.3389/fonc.2022.931294. eCollection 2022.
7
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma.评估当代儿童肿瘤学组针对晚期霍奇金淋巴瘤开展的AHOD1331试验中质子放射治疗使用情况的差异。
Int J Part Ther. 2021 Oct 28;8(3):55-57. doi: 10.14338/IJPT-21-00012.1. eCollection 2022 Winter.
8
A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors.一项针对局限性中枢神经系统生殖细胞肿瘤的基于反应的放射治疗2期试验：非生殖细胞瘤性生殖细胞肿瘤的失败模式和放射剂量测定
Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):143-151. doi: 10.1016/j.ijrobp.2021.12.166. Epub 2022 Jan 4.
9
Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.高危霍奇金淋巴瘤基于缓解的治疗的 3 期研究中的初始复发模式（AHOD0831）：来自儿童肿瘤协作组的报告。
Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):890-900. doi: 10.1016/j.ijrobp.2021.10.152. Epub 2021 Nov 9.
10
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.III 期临床试验：在非转移性尤文肉瘤患者的初始治疗中添加长春新碱-拓扑替康-环磷酰胺：儿童肿瘤学组报告。
J Clin Oncol. 2021 Dec 20;39(36):4029-4038. doi: 10.1200/JCO.21.00358. Epub 2021 Oct 15.
Zotero 插件